RUNX3 and asthma: As is well reviewed elsewhere, genome wide association studies (GWAS) linked RUNX3 with diseases of inflammation in humans including ulcerative colitis, celiac disease, ankylosing spondylitis, psoriasis, and asthma (Lotem et al., 2015).